Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
2,608
Views
5
CrossRef citations to date
0
Altmetric
Articles

Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations

Lili Zhoua National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China;b Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Jingnan Ana National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China;b Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Chang Houa National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Zixuan Dinga National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Huiying Qiua National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Xiaowen Tanga National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Aining Suna National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Suning Chena National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Yang Xua National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China;b Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Tianhui Liua National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China;b Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
&
Depei Wua National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China;b Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
 show all
Pages 340-347 | Published online: 10 Apr 2021

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiaoxuan Lai, Jinyan Xiao, Tanzhen Wang, Chang Hou, Jia Chen, Depei Wu & Yang Xu. Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission. Leukemia & Lymphoma 0:0, pages 1-9.
Read now

Articles from other publishers (4)

Ao Zhang, Shuxing Wang, Quanlei Ren, Yizhu Wang & Zhiping Jiang. (2022) Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis . Asia-Pacific Journal of Clinical Oncology.
Crossref
Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca, Aiwen Zhang, Dawn Thomas, Valeria Visconte, Jibran Durrani, Ronald M. Sobecks, Matt Kalaycio, Aaron T. Gerds, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Anjali S. Advani, Navneet S. Majhail, Betty K. Hamilton, Bhumika J. Patel & Jaroslaw P. Maciejewski. (2022) Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. Bone Marrow Transplantation 57:10, pages 1615-1619.
Crossref
Mohammad Parsa‐kondelaji, Hossein Ayatollahi, Mehrdad Rostami, Maryam Sheikhi, Faezeh Barzegar, Monnavar Afzalaghaee, Elmira Moradi, Mohammad Hadi Sadeghian & Amir Abbas Momtazi‐Borojeni. (2022) Evaluating the frequency, prognosis and survival of RUNX1 and ASXL1 mutations in patients with acute myeloid leukaemia in northeastern Iran . Journal of Cellular and Molecular Medicine 26:13, pages 3797-3801.
Crossref
Yi Fan, Linxiao Liao, Yajun Liu, Zhenzhen Wu, Chong Wang, Zhongxing Jiang, Shujuan Wang & Yanfang Liu. (2021) Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia. Cancer Cell International 21:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.